Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 13, 2011

NOVEN PHARMACEUTICALS v. WATSON LABORATORIES, INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 20, 2014

    Actavis, Noven Reach Deal Over Generic ADHD Patch Plans

    Actavis PLC has reached a licensing deal with Noven Pharmaceuticals Inc. to make a generic version of Noven's attention deficit hyperactivity disorder treatment Daytrana, it announced Wednesday, ending patent litigation over the drug in New Jersey federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login